6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
Just now	Carpenter Technology Reports Third Quarter Fiscal Year 2026 Results
Just now	Fully Booked Momentus Mission Advances Through Preliminary Design Review, Driving Toward 2027 Launch Under NASA Contracts
Just now	Willow Lane Acquisition Corp. Announces No Redemptions in Connection with Business Combination with Boost Run Holdings, LLC
Just now	Rein Therapeutics Provides Clinical Trial Update for Phase 2 RENEW Study of LTI-03 in Idiopathic Pulmonary Fibrosis
Just now	ZJK Industrial Co., Ltd. Reports Financial Results for Fiscal Year 2025

About

Nurexone Biologic Inc. (V:NRX) — investor relations, events, news, and company updates on 6ix.

Latest News

Australian Patent Granted to NurExone Covering Stem Cell-Derived Exosome Production

NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2025 Financial Results and Provides Corporate Update

NurExone to Participate in Water Tower Research Insights Conference on April 14, 2026

NurExone Biologic's U.S. Subsidiary Exo-Top and Florida-Based BioXtek Sign Strategic LOI for Exosome Manufacturing and Commercialization

NurExone Biologic’s U.S. Subsidiary Exo-Top and Florida-Based BioXtek Sign Strategic LOI for Exosome Manufacturing and Commercialization

Financials

Revenue

CA$0

Market Cap

CA$58.94 M

EPS

-0.11

Community Chat

Ask AI